Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tecarfarin (2 trials)
warfarin (coumadin) (1 trial)
budiodarone (1 trial)
naronapride (2 trials)
Atrial Fibrillation (Phase 3)
Atrial Flutter (Phase 3)
Cardiomyopathies (Phase 3)
Infarction (Phase 3)
Myocardial Infarction (Phase 3)
Syndrome (Phase 2)
Thromboembolism (Phase 3)
Trials (5 total)
Trial APIs (4 total)